Arcus Biosciences, Inc.’s $75,000,000 “at-the-market” offering of shares

Cooley advised Arcus Biosciences. Gunderson Dettmer advised Cantor Fitzgerald & Co. acting as underwriter on the offering. Arcus Biosciences, Inc. executed its $75 million “At-the-Market” offering…